Floatz logo

Zoladex

Insomnia

Brasilia University HospitalPhase 3Dormant
B
62/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
89/ 100

Competitive context

8 Active assets in the Insomnia cohort.

Asset / SponsorPhaseRating
Eszopiclone
University of California, Los Angeles
Phase 4A
Cipralex
University of California, Los Angeles
Phase 4BBB
LEMBOREXANT
YangPan
Phase 4BBB
Suvorexant
Mayo Clinic
Phase 4BBB
ZOLPIDEM
Brasilia University Hospital
Phase 4BB

View all 34 →

Same molecule, other indications

Zoladex is also rated in:

HR+/HER2- Breast CancerDormant
BB
Indicative ·
71 / 100
View asset →
prostate neoplasmDormant
BB
Indicative ·
69 / 100
View asset →
prostate adenocarcinomaDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →